Ardelyx (ARDX) Change in Receivables (2013 - 2026)
Ardelyx (ARDX) posted Change in Receivables of $11.0 million for Q1 2026, up 330.83% on a QoQ basis from -$4.8 million in Q4 2025, and up 197.81% year-over-year from $3.7 million in Q1 2025.
Ardelyx (ARDX) Change in Receivables (2013 - 2026) Analysis & Trends
Ardelyx's Change in Receivables history runs 11 years deep, the most recent figure standing at $11.0 million for Q1 2026.
- Quarterly Change in Receivables rose 197.81% year-over-year to $11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.4 million (up 98.71% YoY) and the FY2025 annual result came in at $14.1 million, down 60.35% from the prior year.
- Change in Receivables was $11.0 million for Q1 2026 at Ardelyx, up from -$4.8 million in the prior quarter.
- Across five years, Change in Receivables topped out at $34.2 million in Q3 2023 and bottomed at -$21.2 million in Q4 2023.
- A 5-year average of $4.8 million and a median of $4.4 million in 2023 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 8329.88% in 2023, while the deepest fall reached 940.87% in 2023.
- Ardelyx's Change in Receivables stood at $2.5 million in 2022, then plunged by 940.87% to -$21.2 million in 2023, then soared by 121.24% to $4.5 million in 2024, then plunged by 205.59% to -$4.8 million in 2025, then surged by 330.83% to $11.0 million in 2026.
- Business Quant data shows ARDX's Change in Receivables at $11.0 million in Q1 2026, -$4.8 million in Q4 2025, and $14.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ardelyx | 1.24 Bn | 999.81 Mn | 89.66 Mn | 10.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.99 Mn |
| Mar 31, 2026 | 10.99 Mn |
| Dec 31, 2025 | -4.76 Mn |
| Dec 31, 2025 | -4.76 Mn |
| Sep 30, 2025 | 14.06 Mn |
| Sep 30, 2025 | 14.06 Mn |
| Jun 30, 2025 | 16.09 Mn |
| Jun 30, 2025 | 16.09 Mn |
| Mar 31, 2025 | -11.24 Mn |
| Mar 31, 2025 | -11.24 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Sep 30, 2024 | 15.95 Mn |
| Sep 30, 2024 | 15.95 Mn |
| Jun 30, 2024 | 9.08 Mn |
| Jun 30, 2024 | 9.08 Mn |
| Mar 31, 2024 | 6.13 Mn |
| Mar 31, 2024 | 6.13 Mn |
| Dec 31, 2023 | -21.23 Mn |
| Dec 31, 2023 | -21.23 Mn |